KIKA Merger Proxy Reveals 1,567% Revenue Surge and 66% Customer Concentration
WTG is trading near its 52-week low of $9.74 (8.4% above the low).
Summary
Wintergreen's latest S-4 amendment reveals KIKA's FY2026 revenue surged to $21.84M but with 66% customer concentration and 9% retention, plus a new sponsor note extending the merger deadline to September 30, 2026.
Key Events · M&A and Partnerships · WTG
-
KIKA FY2026 Revenue Surges 1,567%
Audited financials show KIKA revenue jumped from $1.31M in FY2025 to $21.84M in FY2026, with net income of $683,578 versus a prior-year loss of $172,819.
-
66% Revenue Concentration in Four Clients
Four key clients generated 66% of FY2026 revenue, while customer retention rate fell to 9% from 29% — a fragile growth profile.
-
New $184,635 Sponsor Note Extends Deadline
A non-interest-bearing promissory note issued September 1, 2026 funds a one-month extension of the business combination deadline to September 30, 2026, convertible into units at $10.00.
-
Minimum Cash Condition at Risk
Pro forma analysis shows redemptions exceeding 93.28% would drop net tangible assets below the $5,000,001 minimum cash condition, potentially terminating the merger.
Analysis · WTG · Life Sciences
This sixth S-4 amendment adds audited FY2026 financials showing KIKA's revenue exploded from $1.31M to $21.84M, but the growth is highly concentrated — four clients account for 66% of revenue and customer retention collapsed to 9%. The filing also discloses a new $184,635 sponsor note to extend the merger deadline to September 30, 2026, and warns that redemptions above 93.28% would breach the $5M minimum cash condition. For a SPAC trading near its 52-week high, the combination of explosive but fragile revenue growth and a tight cash condition makes this a critical update for shareholders deciding whether to redeem or hold through the merger.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 30.2% of the 1961 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, WTG was trading at $10.56 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $18M. The 52-week trading range was $9.74 to $10.62. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.